サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1460579

siRNA医薬品の世界市場：実績と予測（2023年～2029年）

Global siRNA Drug Market Report, History and Forecast 2023-2029
出版日: | 発行: QYResearch | ページ情報: 英文 99 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
siRNA医薬品の世界市場：実績と予測（2023年～2029年）
出版日: 2024年04月08日
発行: QYResearch
ページ情報: 英文 99 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のsiRNA医薬品の市場規模は、2023年に15億9,651万米ドルとなりました。

同市場は、2030年には128億9,237万米ドルに達すると予測され、予測期間の2024年～2030年のCAGRは31.94%になると予測されています。

米国のsiRNA医薬品の市場規模は、2023年に9億204万米ドルとなりました。同市場は、2024年から2030年の予測期間中に25.58％のCAGRで拡大し、2030年までに52億2,055万米ドルに達すると予測されています。

欧州のsiRNA医薬品の市場規模は、2023年に5億585万米ドルとなりました。同市場は、2024年から2030年の予測期間中に34.51％のCAGRで拡大し、2030年までに45億4,073万米ドルに達すると予測されています。

その他の地域のsiRNA医薬品の市場規模は、2023年に1億8,862万米ドルとなりました。同市場は、2024年から2030年の予測期間中に44.32％のCAGRで拡大し、2030年までに31億3,109万米ドルに達すると予測されています。

当レポートでは、世界のsiRNA医薬品市場について調査し、市場の概要とともに、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 siRNA医薬品の市場概要

  • siRNA医薬品市場概要
  • 世界のsiRNA医薬品市場規模概要、地域別、2019年VS 2023年VS 2030年
  • siRNA医薬品市場規模、地域別（2019年～2030年）
  • 主要地域siRNA医薬品市場規模（2019年～2030年）

第2章 siRNA医薬品市場、タイプ別

  • イントロダクション
  • 世界のsiRNA医薬品市場規模、タイプ別：2019年対2023年対2030年
  • 主要地域市場規模、タイプ別

第3章 siRNA医薬品市場概要、用途別

  • イントロダクション
  • 世界のsiRNA医薬品市場規模、用途別：2019年VS 2023年VS 2030年
  • 主要地域市場規模、用途別

第4章 FDA承認のsiRNA医薬品

第5章 siRNA医薬品の競合分析

第6章 米国

第7章 欧州

第8章 その他の地域

第9章 主要企業プロファイル

  • Alnylam
  • Novartis
  • Novo Nordisk
  • Genzyme
  • Arrowhead
  • Silence
  • Sylentis
  • Avidity Biosciences
  • Sirnaomics

第10章 siRNA医薬品産業チェーン、主要原材料および上流コスト分析

第11章 siRNA医薬品市場力学

  • siRNA医薬品業界の動向
  • siRNA医薬品市場の促進要因
  • siRNA医薬品市場の課題
  • siRNA医薬品市場の抑制要因

第12章 siRNA医薬品開発の実績と今後の見通し

第13章 調査結果/結論

第14章 調査手法とデータソース

図表

List of Tables

  • Table 1. Global Market siRNA Drug Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
  • Table 2. Global siRNA Drug Market Size by Region (2019-2024) & (US$ Million)
  • Table 3. Global siRNA Drug Market Size Share by Region (2019-2024)
  • Table 4. Global siRNA Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
  • Table 5. Global siRNA Drug Forecasted Market Size Share by Region (2025-2030)
  • Table 6. Global siRNA Drug Market Size (US$ Million) by Type: 2019 VS 2023 VS 2030
  • Table 7. Global siRNA Drug Market Size by Type (2019-2024) & (US$ Million)
  • Table 8. Global siRNA Drug Revenue Market Share by Type (2019-2024)
  • Table 9. Global siRNA Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
  • Table 10. Global siRNA Drug Revenue Market Share by Type (2025-2030)
  • Table 11. United States siRNA Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 12. United States siRNA Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 13. Europe siRNA Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 14. Europe siRNA Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 15. Rest of World siRNA Drug Revenue by Type (2019-2024) & (US$ Million)
  • Table 16. Rest of World siRNA Drug Revenue by Type (2025-2030) & (US$ Million)
  • Table 17. Global siRNA Drug Revenue by Application: (US$ Million) 2019 VS 2023 VS 2030
  • Table 18. Global siRNA Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 19. Global siRNA Drug Revenue Market Share by Application (2019-2024)
  • Table 20. Global siRNA Drug Forecasted Revenue by Application (2025-2030) & (US$ Million)
  • Table 21. Global siRNA Drug Revenue Market Share by Application (2025-2030)
  • Table 22. United States siRNA Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 23. United States siRNA Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 24. Europe siRNA Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 25. Europe siRNA Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 26. Rest of World siRNA Drug Revenue by Application (2019-2024) & (US$ Million)
  • Table 27. Rest of World siRNA Drug Revenue by Application (2025-2030) & (US$ Million)
  • Table 28. Global siRNA Drug Revenue by Players (2019-2024) & (US$ Million)
  • Table 29. Global siRNA Drug Revenue Market Share by Players (2019-2024)
  • Table 30. Global Top Players Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drug as of 2023)
  • Table 31. Global Key Players of siRNA Drug, Headquarters and Area Served
  • Table 32. Global Key Players of siRNA Drug and Product Research Progress
  • Table 33. Global Key Players of siRNA Drug, Establishment Time
  • Table 34. Global siRNA Drug Players Market Concentration Ratio (CR3)
  • Table 35. United States siRNA Drug Market Size Growth Rate (CAGR) (US$ Million): 2019 VS 2023 VS 2030
  • Table 36. Europe siRNA Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 37. Europe siRNA Drug Market Size by Country (2019-2024) & (US$ Million)
  • Table 38. Europe siRNA Drug Market Size by Country (2025-2030) & (US$ Million)
  • Table 39. Europe siRNA Drug Market Share by Country (2019-2024)
  • Table 40. Europe siRNA Drug Market Share by Country (2025-2030)
  • Table 41. Rest of World siRNA Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 42. Rest of World siRNA Drug Market Size by Region (2019-2024) & (US$ Million)
  • Table 43. Rest of World siRNA Drug Market Size by Region (2025-2030) & (US$ Million)
  • Table 44. Rest of World siRNA Drug Market Share by Region (2019-2024)
  • Table 45. Rest of World siRNA Drug Market Share by Region (2025-2030)
  • Table 46. Alnylam Basic Information List
  • Table 47. Alnylam Description and Business Overview
  • Table 48. Alnylam siRNA Drug Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in siRNA Drug Business of Alnylam (2019-2024)
  • Table 50. Alnylam Recent Developments
  • Table 51. Novartis Basic Information List
  • Table 52. Novartis Description and Business Overview
  • Table 53. Novartis siRNA Drug Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in siRNA Drug Business of Novartis (2019-2024)
  • Table 55. Novartis Recent Developments
  • Table 56. Novo Nordisk Basic Information List
  • Table 57. Novo Nordisk Description and Business Overview
  • Table 58. Novo Nordisk siRNA Drug Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in siRNA Drug Business of Novo Nordisk (2019-2024)
  • Table 60. Novo Nordisk Recent Developments
  • Table 61. Genzyme Basic Information List
  • Table 62. Genzyme Description and Business Overview
  • Table 63. Genzyme siRNA Drug Products, Services and Solutions
  • Table 64. Genzyme Recent Developments
  • Table 65. Arrowhead Basic Information List
  • Table 66. Arrowhead Description and Business Overview
  • Table 67. Arrowhead siRNA Drug Products, Services and Solutions
  • Table 68. Arrowhead Recent Developments
  • Table 69. Silence Basic Information List
  • Table 70. Silence Description and Business Overview
  • Table 71. Silence siRNA Drug Products, Services and Solutions
  • Table 72. Silence Recent Developments
  • Table 73. Sylentis Basic Information List
  • Table 74. Sylentis Description and Business Overview
  • Table 75. Sylentis siRNA Drug Products, Services and Solutions
  • Table 76. Sylentis Recent Developments
  • Table 77. Avidity Biosciences Basic Information List
  • Table 78. Avidity Biosciences Description and Business Overview
  • Table 79. Avidity Biosciences siRNA Drug Products, Services and Solutions
  • Table 80. Avidity Biosciences Recent Developments
  • Table 81. Sirnaomics Basic Information List
  • Table 82. Sirnaomics Description and Business Overview
  • Table 83. Sirnaomics siRNA Drug Products, Services and Solutions
  • Table 84. Sirnaomics Recent Developments
  • Table 85. Key Raw Materials Lists
  • Table 86. siRNA Drug Market Trends
  • Table 87. siRNA Drug Market Drivers
  • Table 88. siRNA Drug Market Challenges
  • Table 89. siRNA Drug Market Restraints
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources

List of Figures

  • Figure 1. siRNA Drug Product Picture
  • Figure 2. Global siRNA Drug Market Size Year-over-Year (2019-2030) & (US$ Million)
  • Figure 3. Global siRNA Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 4. Global siRNA Drug Market Share by Region: 2023 VS 2030
  • Figure 5. Global siRNA Drug Forecasted Market Size Share by Region (2019-2030)
  • Figure 6. United States siRNA Drug Market Size Growth Rate (2019-2030) & (US$ Million)
  • Figure 7. Europe siRNA Drug Market Size Growth Rate (2019-2030) & (US$ Million)
  • Figure 8. Rest of World siRNA Drug Market Size Growth Rate (2019-2030) & (US$ Million)
  • Figure 9. Product Picture of Intravenous Injection
  • Figure 10. Global Intravenous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 11. Product Picture of Subcutaneous Injection
  • Figure 12. Global Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 13. Global siRNA Drug Market Size Share by Type: 2023 & 2030
  • Figure 14. United States siRNA Drug Revenue Market Share by Type (2019-2030)
  • Figure 15. Europe siRNA Drug Revenue Market Share by Type (2019-2030)
  • Figure 16. Rest of World siRNA Drug Revenue Market Share by Type (2019-2030)
  • Figure 17. Nervous System Therapy Market Size (US$ Million) & YoY Growth (2019-2030)
  • Figure 18. Endocrine and Metabolic Therapy Market Size (US$ Million) & YoY Growth (2019-2030)
  • Figure 19. Others Market Size (US$ Million) & YoY Growth (2019-2030)
  • Figure 20. Global siRNA Drug Revenue Share by Application: 2023 & 2030
  • Figure 21. United States siRNA Drug Revenue Market Share by Application (2019-2030)
  • Figure 22. Europe siRNA Drug Revenue Market Share by Application (2019-2030)
  • Figure 23. Rest of World siRNA Drug Revenue Market Share by Application (2019-2030)
  • Figure 24. FDA-Approved siRNA Drugs
  • Figure 25. The Top 2 Players Market Share by siRNA Drug Sales in 2023
  • Figure 26. United States siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 27. Germany siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 28. France siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 29. U.K. siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 30. Italy siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 31. Switzerland siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 32. Nordic Countries siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 33. Rest of Europe siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 34. Rest of World siRNA Drug Market Share by Region (2019-2030)
  • Figure 35. Canada siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 36. Japan siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 37. Brazil siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 38. China siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 39. Australia siRNA Drug Market Size (2019-2030) & (US$ Million)
  • Figure 40. siRNA Drug Industrial Chain Analysis
  • Figure 41. Upstream Cost Proportion
  • Figure 42. Mechanism of siRNA Drug
  • Figure 43. Bottom-up and Top-down Approaches for This Report
  • Figure 44. Data Triangulation
目次

The global market for siRNA Drug estimated was at US$ 1,596.51 million in the year 2023, is projected to reach a revised size of US$ 12,892.37 million by 2030, growing at a CAGR of 31.94% during the forecast period 2024-2030.

United States market for siRNA Drug was valued at $ 902.04 million in 2023 and will reach $ 5,220.55 million by 2030, at a CAGR of 25.58% during the forecast period of 2024 through 2030.

Europe market for siRNA Drug was valued at $ 505.85 million in 2023 and will reach $ 4,540.73 million by 2030, at a CAGR of 34.51 % during the forecast period of 2024 through 2030.

Rest of World market for siRNA Drug was valued at $ 188.62 million in 2023 and will reach $ 3,131.09 million by 2030, at a CAGR of 44.32 % during the forecast period of 2024 through 2030.

This report aims to provide a comprehensive presentation of the global market for siRNA Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding siRNA Drug.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global siRNA Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the siRNA Drug segments by company, by Type, by Application, by region and country, and provides market size and CAGR for the history and forecast period (2019-2024, 2025-2030), considering 2023 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

  • Alnylam
  • Novartis
  • Novo Nordisk
  • Genzyme
  • Arrowhead
  • Silence
  • Sylentis
  • Avidity Biosciences
  • Sirnaomics

Segment by Type

  • Intravenous Injection
  • Subcutaneous Injection

Segment by Application

  • Nervous System Therapy
  • Endocrine and Metabolic Therapy
  • Others

By Region

  • United States
  • Rest of World
  • Canada
  • Japan
  • Brazil
  • China
  • Australia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Switzerland
  • Nordic Countries
  • Rest of Europe

Chapter Outline

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Details of FDA-Approved siRNA Drugs

Chapter Five: Detailed analysis of siRNA Drug companies' competitive landscape, revenue, market share and ranking, etc.

Chapter Six, Seven and Eight: United States, Europe and rest of world revenue by country.

Chapter Nine: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Ten: Provides siRNA Drug Industry Chain, Key Raw Materials and Upstream Cost Analysis

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: About siRNA Drug Development History and Future Outlook

Chapter Thirteen: Research Finding/Conclusion

Table of Contents

1 Market Overview of siRNA Drug

  • 1.1 siRNA Drug Market Overview
    • 1.1.1 siRNA Drug Product Scope
    • 1.1.2 siRNA Drug Market Status and Outlook
  • 1.2 Global siRNA Drug Market Size Overview by Region 2019 VS 2023 VS 2030
  • 1.3 Global siRNA Drug Market Size by Region (2019-2030)
    • 1.3.1 Global siRNA Drug Historic Market Size by Region (2019-2024)
    • 1.3.2 Global siRNA Drug Market Size Forecast by Region (2025-2030)
  • 1.4 Key Regions siRNA Drug Market Size (2019-2030)
    • 1.4.1 United States siRNA Drug Market Size (2019-2030)
    • 1.4.2 Europe siRNA Drug Market Size (2019-2030)
    • 1.4.3 Rest of World siRNA Drug Market Size (2019-2030)

2 siRNA Drug Market by Type

  • 2.1 Introduction
    • 2.1.1 Intravenous Injection
    • 2.1.2 Subcutaneous Injection
  • 2.2 Global siRNA Drug Market Size by Type: 2019 VS 2023 VS 2030
    • 2.2.1 Global siRNA Drug Historic Market Size by Type (2019-2024)
    • 2.2.2 Global siRNA Drug Forecasted Market Size by Type (2025-2030)
  • 2.3 Key Regions Market Size by Type
    • 2.3.1 United States siRNA Drug Revenue Breakdown by Type (2019-2030)
    • 2.3.2 Europe siRNA Drug Revenue Breakdown by Type (2019-2030)
    • 2.3.3 Rest of World siRNA Drug Revenue Breakdown by Type (2019-2030)

3 siRNA Drug Market Overview by Application

  • 3.1 Introduction
    • 3.1.1 Nervous System Therapy
    • 3.1.2 Endocrine and Metabolic Therapy
    • 3.1.3 Others
  • 3.2 Global siRNA Drug Market Size by Application: 2019 VS 2023 VS 2030
    • 3.2.1 Global siRNA Drug Historic Revenue by Application (2019-2024)
    • 3.2.2 Global siRNA Drug Forecasted Revenue by Application (2025-2030)
  • 3.3 Key Regions Market Size by Application
    • 3.3.1 United States siRNA Drug Revenue Breakdown by Application (2019-2030)
    • 3.3.2 Europe siRNA Drug Revenue Breakdown by Application (2019-2030)
    • 3.3.3 Rest of World siRNA Drug Revenue Breakdown by Application (2019-2030)

4 FDA-Approved siRNA Drugs

5 siRNA Drug Competition Analysis by Players

  • 5.1 Global siRNA Drug Market Size by Players (2019-2024)
  • 5.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drug as of 2023)
  • 5.3 Global Key Players of siRNA Drug Head office
  • 5.4 Global Key Players of siRNA Drug and Product Research Progress
  • 5.5 Global Key Players of siRNA Drug and Establishment Time
  • 5.6 siRNA Drug Market Concentration Rate

6 United States

  • 6.1 United States siRNA Drug Market Size (2019-2030)
  • 6.2 United States

7 Europe

  • 7.1 Europe siRNA Drug Market Size by Country (2019-2030)
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Switzerland
  • 7.7 Nordic Countries
  • 7.8 Rest of Europe

8 Rest of World

  • 8.1 Rest of World siRNA Drug Market Size by Region (2019-2030)
  • 8.2 Canada
  • 8.3 Japan
  • 8.4 Brazil
  • 8.5 China
  • 8.6 Australia

9 Company (Top Players) Profiles

  • 9.1 Alnylam
    • 9.1.1 Alnylam Profile
    • 9.1.2 Alnylam Main Business
    • 9.1.3 Alnylam siRNA Drug Products, Services and Solutions
    • 9.1.4 Alnylam siRNA Drug Revenue (US$ Million) & (2019-2024)
    • 9.1.5 Alnylam Recent Developments
  • 9.2 Novartis
    • 9.2.1 Novartis Profile
    • 9.2.2 Novartis Main Business
    • 9.2.3 Novartis siRNA Drug Products, Services and Solutions
    • 9.2.4 Novartis siRNA Drug Revenue (US$ Million) & (2019-2024)
    • 9.2.5 Novartis Recent Developments
  • 9.3 Novo Nordisk
    • 9.3.1 Novo Nordisk Profile
    • 9.3.2 Novo Nordisk Main Business
    • 9.3.3 Novo Nordisk siRNA Drug Products, Services and Solutions
    • 9.3.4 Novo Nordisk siRNA Drug Revenue (US$ Million) & (2019-2024)
    • 9.3.5 Novo Nordisk Recent Developments
  • 9.4 Genzyme
    • 9.4.1 Genzyme Profile
    • 9.4.2 Genzyme Main Business
    • 9.4.3 Genzyme siRNA Drug Products, Services and Solutions
    • 9.4.4 Genzyme Recent Developments
  • 9.5 Arrowhead
    • 9.5.1 Arrowhead Profile
    • 9.5.2 Arrowhead Main Business
    • 9.5.3 Arrowhead siRNA Drug Products, Services and Solutions
    • 9.5.4 Arrowhead Recent Developments
  • 9.6 Silence
    • 9.6.1 Silence Profile
    • 9.6.2 Silence Main Business
    • 9.6.3 Silence siRNA Drug Products, Services and Solutions
    • 9.6.4 Silence Recent Developments
  • 9.7 Sylentis
    • 9.7.1 Sylentis Profile
    • 9.7.2 Sylentis Main Business
    • 9.7.3 Sylentis siRNA Drug Products, Services and Solutions
    • 9.7.4 Sylentis Recent Developments
  • 9.8 Avidity Biosciences
    • 9.8.1 Avidity Biosciences Profile
    • 9.8.2 Avidity Biosciences Main Business
    • 9.8.3 Avidity Biosciences siRNA Drug Products, Services and Solutions
    • 9.8.4 Avidity Biosciences Recent Developments
  • 9.9 Sirnaomics
    • 9.9.1 Sirnaomics Profile
    • 9.9.2 Sirnaomics Main Business
    • 9.9.3 Sirnaomics siRNA Drug Products, Services and Solutions
    • 9.9.4 Sirnaomics Recent Developments

10 siRNA Drug Industry Chain, Key Raw Materials and Upstream Cost Analysis

  • 10.1 siRNA Drug Industrial Chain Analysis
  • 10.2 siRNA Drug Key Raw Materials
  • 10.3 Upstream Cost Proportion

11 siRNA Drug Market Dynamics

  • 11.1 siRNA Drug Industry Trends
  • 11.2 siRNA Drug Market Drivers
  • 11.3 siRNA Drug Market Challenges
  • 11.4 siRNA Drug Market Restraints

12 siRNA Drug Development History and Future Outlook

  • 12.1 Evolution of siRNA Drug
  • 12.2 Mechanism of siRNA Drug: Targeted Gene Silencing with High Specificity
  • 12.3 Limitations and Improvement Strategies of siRNA Drug

13 Research Finding/Conclusion

14 Methodology and Data Source

  • 14.1 Methodology/Research Approach
    • 14.1.1 Research Programs/Design
    • 14.1.2 Market Size Estimation
    • 14.1.3 Market Breakdown and Data Triangulation
  • 14.2 Data Source
    • 14.2.1 Secondary Sources
    • 14.2.2 Primary Sources
  • 14.3 Author List
  • 14.4 Disclaimer